Tower Research Capital (TRC)’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,844
Closed -$3K 6534
2023
Q1
$3K Sell
7,844
-3,676
-32% -$1.41K ﹤0.01% 5291
2022
Q4
$8K Buy
11,520
+1,813
+19% +$1.26K ﹤0.01% 4512
2022
Q3
$12K Buy
9,707
+3,452
+55% +$4.27K ﹤0.01% 4406
2022
Q2
$7K Buy
6,255
+2,519
+67% +$2.82K ﹤0.01% 4861
2022
Q1
$8K Buy
+3,736
New +$8K ﹤0.01% 4647
2021
Q4
Sell
-302
Closed -$1K 6805
2021
Q3
$1K Buy
302
+127
+73% +$421 ﹤0.01% 5600
2021
Q2
$1K Buy
+175
New +$1K ﹤0.01% 5313
2021
Q1
Sell
-4,336
Closed -$15K 5867
2020
Q4
$15K Buy
+4,336
New +$15K ﹤0.01% 4073
2020
Q3
Sell
-7,030
Closed -$52K 5206
2020
Q2
$52K Sell
7,030
-5,887
-46% -$43.5K ﹤0.01% 3022
2020
Q1
$61K Buy
12,917
+12,100
+1,481% +$57.1K ﹤0.01% 1203
2019
Q4
$10K Buy
+817
New +$10K ﹤0.01% 2355
2019
Q3
Sell
-2,463
Closed -$42K 4660
2019
Q2
$42K Buy
2,463
+2,309
+1,499% +$39.4K ﹤0.01% 1716
2019
Q1
$5K Sell
154
-84
-35% -$2.73K ﹤0.01% 3112
2018
Q4
$7K Sell
238
-49
-17% -$1.44K ﹤0.01% 2733
2018
Q3
$18K Buy
287
+85
+42% +$5.33K ﹤0.01% 2431
2018
Q2
$15K Sell
202
-974
-83% -$72.3K ﹤0.01% 2601
2018
Q1
$77K Buy
+1,176
New +$77K 0.01% 1435
2017
Q4
Sell
-530
Closed -$61K 4280
2017
Q3
$61K Buy
+530
New +$61K 0.01% 1795
2017
Q2
Sell
-10
Closed -$1K 3759
2017
Q1
$1K Sell
10
-530
-98% -$53K ﹤0.01% 2885
2016
Q4
$73K Buy
540
+529
+4,809% +$71.5K 0.01% 1155
2016
Q3
$2K Buy
+11
New +$2K ﹤0.01% 3167
2016
Q2
Sell
-174
Closed -$16K 5156
2016
Q1
$16K Sell
174
-79
-31% -$7.26K ﹤0.01% 1525
2015
Q4
$52K Buy
253
+230
+1,000% +$47.3K 0.01% 543
2015
Q3
$3K Sell
23
-7
-23% -$913 ﹤0.01% 3195
2015
Q2
$6K Sell
30
-181
-86% -$36.2K ﹤0.01% 3163
2015
Q1
$49K Buy
+211
New +$49K 0.01% 1486